Aeon Biopharma Inc (AEON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,006 | 5,927 | 8,439 | 10,446 | 13 |
| TOTAL | $3,398 | $7,412 | $10,262 | $12,321 | $1,590 |
| Non-Current Assets | |||||
| PPE Net | 162 | 181 | 200 | 220 | 235 |
| Other Non-Current Assets | 2,000 | 1,141 | 1,200 | 1,258 | 1,317 |
| TOTAL | $2,162 | $1,322 | $1,400 | $1,478 | $1,552 |
| Total Assets | $5,560 | $8,734 | $11,662 | $13,799 | $3,142 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 942 | 2,525 | 3,907 | 2,437 | 5,910 |
| Accrued Expenses | 4,298 | 3,071 | 2,221 | 3,444 | 4,639 |
| Other current liabilities | 1,657 | 2,632 | 3,001 | 2,759 | 3,600 |
| TOTAL | $6,897 | $8,228 | $9,129 | $8,640 | $14,149 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 53,690 | 20,378 | 18,385 | 16,482 | 17,562 |
| TOTAL | $53,690 | $20,378 | $18,385 | $16,482 | $17,562 |
| Total Liabilities | $60,587 | $28,606 | $27,514 | $25,122 | $31,711 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 25,303 | 11,838 | 11,644 | 11,305 | 10,533 |
| Common Shares | 9 | 9 | 9 | 9 | 4 |
| Retained earnings | -470,819 | -433,682 | -429,144 | -422,502 | -431,597 |
| TOTAL | $-55,027 | $-19,872 | $-15,852 | $-11,323 | $-28,569 |
| Total Liabilities And Equity | $5,560 | $8,734 | $11,662 | $13,799 | $3,142 |